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Abstract
Background: Abdominal infections are frequent causes of sepsis and septic shock in the intensive care unit (ICU)
and are associated with adverse outcomes. We analyzed the characteristics, treatments and outcome of ICU
patients with abdominal infections using data extracted from a one-day point prevalence study, the Extended
Prevalence of Infection in the ICU (EPIC) II.
Methods: EPIC II included 13,796 adult patients from 1,265 ICUs in 75 countries. Infection was defined using the
International Sepsis Forum criteria. Microbiological analyses were performed locally. Participating ICUs provided
patient follow-up until hospital discharge or for 60 days.
Results: Of the 7,087 infected patients, 1,392 (19.6%) had an abdominal infection on the study day (60% male,
mean age 62 ± 16 years, SAPS II score 39 ± 16, SOFA score 7.6 ± 4.6). Microbiological cultures were positive in
931 (67%) patients, most commonly Gram-negative bacteria (48.0%). Antibiotics were administered to 1366
(98.1%) patients. Patients who had been in the ICU for ≤2 days prior to the study day had more Escherichia coli,
methicillin-sensitive Staphylococcus aureus and anaerobic isolates, and fewer enterococci than patients who
had been in the ICU longer. ICU and hospital mortality rates were 29.4% and 36.3%, respectively. ICU mortality
was higher in patients with abdominal infections than in those with other infections (29.4% vs. 24.4%, p < 0.001).
In multivariable analysis, hematological malignancy, mechanical ventilation, cirrhosis, need for renal replacement
therapy and SAPS II score were independently associated with increased mortality.
Conclusions: The characteristics, microbiology and antibiotic treatment of abdominal infections in critically ill
patients are diverse. Mortality in patients with isolated abdominal infections was higher than in those who had
other infections.
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Background
Abdominal infection is a common indication for admission
to the intensive care unit (ICU) and the abdomen is the
second most common site of invasive infection among
critically ill patients in epidemiological [1-3] and thera-
peutic [4] studies. Abdominal infections are more often
associated with septic shock and acute kidney injury
than are infections in other sites [5,6]. The spectrum of
disease and severity is broad and management of these
infections is challenging [7-9].
Multicenter data on the clinical features and micro-
biology of abdominal infections in the critically ill are
rare, and often limited to a single region or country. In
recent years, an increase in abdominal infections due to
nosocomial and resistant organisms has been reported
[10-14], but large-scale data are lacking. Although out-
comes may have improved over the years [15], abdom-
inal infections still carry a significant mortality risk.
Isolation of nosocomial microorganisms [16], entero-
cocci [17] or fungi [18,19] is often cited as contributing
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to mortality, but the extent to which these organisms con-
tribute to that risk is unknown. The role of comorbidities
as well as demographic characteristics has also not been
studied on a large scale. Prolonged stay in a critical care en-
vironment may be associated with changes in microbiology,
thus affecting empirical antibiotic treatment, yet recent
guidelines do not include length of stay as a potential surro-
gate marker for the presence of nosocomial or less suscep-
tible microorganisms [20].
The Extended Prevalence of Infection in the ICU
(EPIC) II study was a large one-day point-prevalence
study of infections in the ICU. The study showed that
half of all ICU patients were infected on the study day
and 71% were being treated with antibiotics [1]. We used
the data collected in the EPIC II study to (1) analyze the
characteristics of abdominal infections (patient charac-
teristics, micro-organisms) as well as the antibiotics used
to treat these infections; (2) explore the differences in
microbiology according to the length of stay in the ICU;
and (3) identify clinical and microbiological factors asso-
ciated with mortality.
Methods
The EPIC II study was performed on May 8, 2007.
Demographic, physiological, bacteriological and therapeutic
data were collected from 13,796 adult (>18 years) patients
in 1,265 participating ICUs from 75 countries (see
Appendix for list of participating centers) on the study
day as previously described [1]. The EPIC II study was
approved by the Erasme Hospital ethics committee.
Local ethical committee approval at each participating
center was expedited or waived because of the purely
observational nature of the study. Infection was de-
fined according to the criteria of the International
Sepsis Forum (ISF) [21] and classified by the attending
physician. Microbiological analyses were performed lo-
cally. Participating ICUs were asked to provide patient
follow-up until hospital discharge or for 60 days.
For the purposes of this study, we analyzed data from
the patients who were diagnosed with an intra-abdominal
infection.
Statistics
Statistical analyses were performed using PASW Statistics
18 for windows (SPSS Inc., Chicago, USA). Data are pre-
sented as mean (±standard deviation [SD]), median (inter-
quartile range [IQR]), or number (%) as appropriate. To
identify factors associated with mortality, a multivariable lo-
gistic regression model (single step, forced entry) was con-
structed using variables for which the P-value was <0.1 in
univariable analysis. Goodness of fit was assessed by the
Hosmer-Lemeshow statistic. All tests were two-tailed, and
a P < 0.05 was considered statistically significant.
Results
Of the 7,087 infected patients, 1,392 (19.6%) were diag-
nosed as having an abdominal infection on the study day
(Table 1). Cancer and chronic obstructive pulmonary
disease (COPD) were the most frequent comorbidities.
The majority of the patients (885 [63.7%]) had under-
gone emergency surgery. Other concomitant infections
were frequently present, with respiratory infections and
bloodstream infections occurring in 26.8% and 11.6% of
the patients, respectively (Additional file 1: Table S1).
Table 1 Patient characteristics
Age, mean ± SD, year 62 ± 16
Male, n (%) 831 (60)
SAPS II score, mean ± SD 38.9 ± 16.4
SOFA score, mean ± SD 7.6 ± 4.6
Length of ICU stay before May 8, median (IQR), days 6 (1–15)
Type of admission, n (%)
Surgical - emergency 885 (63.7)
Medical 260 (18.7)
Surgical - elective 198 (14.2)
Trauma 47 (3.4)
Admission source, n (%)
OR/recovery room 488 (35.3)
Hospital floor 465 (33.6)
ER/ambulance 199 (14.4)





Chronic renal failure 140 (10.1)
Insulin dependent diabetes mellitus 131 (9.4)
Heart failure (NYHA III-IV) 107 (7.7)
Cirrhosis 79 (5.7)
Hematological cancer 24 (1.7)
HIV 12 (0.9)
Organ support on the study day
Mechanical ventilation 863 (62.0)
Renal replacement therapy 220 (15.8)
Outcome measures
ICU LOS, median (IQR), days 16 (6–34)
Hospital LOS, median (IQR), days 30 (14–59)
ICU mortality, n (%) 382 (29.4)
Hospital mortality, n (%) 472 (36.3)
SAPS II = Simplified Acute Physiology Score II; SOFA = Sequential Organ Failure
Assessment; HIV = Human Immunodeficiency Virus; NYHA III-IV = New York
Heart Association class III-IV.
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Microbiological data were available for 931 patients
(67%), with a total of 1,289 microorganisms isolated
(Table 2). Polymicrobial infections were present in 40.1%
of the patients. Escherichia coli was isolated most fre-
quently, with Pseudomonas spp. and Klebsiella spp. ranking
second and third among the Gram-negative isolates.
Enterococcus was the most prevalent Gram-positive
isolate. Antibiotic resistance was relatively rare: ampicillin-
resistant enterococci were isolated in 70 patients (7.5%),
methicillin-resistant staphylococci in 59 patients (6.3%).
Candida species were isolated in 156 patients (16.8%),
75.6% of these isolates were Candida albicans.
Almost all the patients with abdominal infections
(98.1%) were receiving antibiotics: penicillins and other
beta-lactam antibiotics (excluding cephalosporins) were
used most frequently (38.6% and 34.4% of the patients,
respectively) (Additional file 1: Table S2); 29.4% of the
patients were receiving antifungal agents.
ICU (median 16 [IQR 6–34] days vs. 17 [7–34] days,
P = 0.07) and hospital (30 [14–59] days vs. 29 [14–56]
days, P = 0.68) lengths of stay (LOS) were similar in pa-
tients with abdominal infections and those with other
infections. Overall ICU and hospital mortality rates were
29.4% and 36.3%, respectively (Table 1). Mortality rates
were higher in patients who had abdominal infections
than in patients from the EPIC II cohort who had other
infections (ICU mortality 29.4% vs. 24.4%, P < 0.001, and
hospital mortality 36.3% vs. 32.3%, P = 0.005). ICU and
hospital mortality rates in non-infected patients in the
EPIC-II cohort were 10.7% and 14.8%, respectively.
Non-survivors were older, had higher SAPS II and
SOFA scores on the study day, and were more likely to
have cirrhosis, heart failure, or hematological cancer.
They were also more likely to be receiving mechanical
ventilation or renal replacement than survivors (Table 3).
Survivors and non-survivors had similar patterns of
infecting organisms, except for P. aeruginosa and Steno-
trophomonas maltophilia, which were isolated more fre-
quently in non-survivors than in survivors (Additional
file 1: Table S3). In multivariable analysis, hematological
cancer, mechanical ventilation, cirrhosis, renal replacement
therapy and SAPS II score on the study day were independ-
ently associated with increased mortality (Table 4).
In patients who had been in the ICU for 2 days or
less prior to the study day, there were more E. coli,
methicillin-sensitive S. aureus and anaerobic isolates
and fewer enterococci than in patients who had been
in the ICU for a longer period of time; there was also a
trend towards fewer P. aeruginosa, Citrobacter spp.
and C. albicans isolates (Table 5).
Discussion
This study is one of the first to look at abdominal infec-
tions in critically ill patients from a global perspective.
Table 2 A total of 1289 micro-organisms were recovered
from the 931 patients with abdominal infections and
positive cultures
n (%)














Pseudomonas, other than P aeruginosa 4
Haemophilus spp. 2
Gram-positive bacteria 366 (28.4%)
Enterococci, ampicillin-sensitive 122
Enterococci, ampicillin-resistant 70








Methicillin-sensitive S. aureus 21
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Gram-positive cocci, other 8
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The results show that abdominal infections are associated
with significant mortality rates and that concomitant infec-
tions are frequent. Microbiology patterns and antibiotic
treatments were diverse in this group of patients, and
pathogens were different in patients who had been in the
ICU for a longer period of time than in those more recently
admitted. The severity of disease and presence of comor-
bidities determined outcome in these patients.
Table 3 Characteristics of survivors and non-survivors
Survivors (n = 917) Non-survivors (n = 382) p
Age, mean ± ± SD 61.6 ± 16.5 65.2 ± 14.9 <0.001
Male, n (%) 546 (59.7) 223 (58.5) 0.7
Severity score on study day
SAPS II, mean ± SD 34.2 ± 13.5 50.1 ± 17 <0.001
SOFA, mean ± SD 6.2 ± 3.8 10.5 ± 4.6 <0.001
ICU stay before May 8, median (IQR) 5 (1–13) 8 (1–18) <0.001
Type of admission, n (%) 0.58
Surgical/elective 124 (13.5) 62 (16.3)
Medical 179 (19.5) 69 (18.2)
Surgical/emergency 580 (63.2) 237 (62.4)
Trauma 34 (3.7) 12 (3.2)
Admission source, n (%) 0.12
OR/recovery room 349 (38.2) 120 (31.7)
Hospital floor 290 (31.8) 141 (37.2)
ER/ambulance 135 (14.8) 50 (13.2)
Other hospital 116 (12.7) 57 (15)
Other 23 (2.5) 11 (2.9)
Comorbidities, n (%)
COPD 149 (16.2) 62 (16.2) 0.99
Cancer 203 (22.1) 97 (25.4) 0.20
Heart failure (NYHA III-IV) 62 (6.8) 40 (10.5) 0.02
Insulin dependent diabetes mellitus 87 (9.5) 37 (9.7) 0.91
Chronic renal failure 83 (9.1) 44 (11.5) 0.17
Cirrhosis 39 (4.3) 33 (8.6) <0.01
Hematological cancer 9 (1.0) 14 (3.7) <0.001
HIV 6 (0.7) 6 (1.6) 0.12
Treatment on the study day, n (%)
Mechanical ventilation 534 (58.2) 329 (86.4) <0.001
RRT (hemodialysis or hemofiltration) 110 (12.0) 110 (28.9) <0.001
Outcome
ICU LOS, median (IQR) 14 (5–32) 18 (9–38) <0.001
Other sites of infection, n (%)
Respiratory 221 (24.1) 120 (31.4) <0.01
Blood stream 97 (10.6) 56 (14.7) 0.04
Renal/urinary tract 53 (5.8) 33 (8.6) 0.06
Skin 29 (3.2) 23 (6) 0.02
Catheter-related 28 (3.1) 21 (5.5) 0.04
CNS 1 (0.1) 0 (0) 0.52
Others 19 (2.1) 16 (4.2) 0.03
SAPS II = Simplified Acute Physiology Score II; SOFA = Sequential Organ Failure Assessment; HIV = Human Immunodeficiency Virus; RRT = renal replacement therapy;
NYHA III-IV = New York Heart Association class III-IV.
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Mortality in patients who had abdominal infections
was significantly higher than in patients who had other
infections (most of which were respiratory infections),
which was not found in previous studies. In an analysis
of patients from the Sepsis Occurrence in Acutely Ill
Patients (SOAP) study, Volakli et al. reported no differ-
ences in mortality rates among patients with abdominal
infections and those with respiratory infections [6]. The
higher mortality rate in patients with abdominal infec-
tions in our study may be explained by a number of
differences between abdominal and other infections.
First, timely source control is particularly important in
the management of abdominal infections [22], and the
method by which source control is obtained may influence
outcomes [23]. Failed source control is often difficult to
identify and can be a cause of persistent infection. In
addition, abdominal infections are typically polymicrobial
and often associated with resistant organisms; in the
current study, non-survivors more frequently had P. aerugi-
nosa and Stenotrophomonas maltophilia as pathogens.
Finally, the large number of concomitant infections may
also have affected outcomes.
As expected, comorbidities, such as cirrhosis and
hematological cancer, were associated with increased
mortality, as was found in the EPIC II patients in gen-
eral [1]. Most notably, the impact of cirrhosis was con-
siderable with a 2.3-fold increase in the risk of death. A
recent analysis of the Project Impact database also
showed that cirrhosis was independently associated
with an increased risk of 30-day mortality [24].
The microbiology patterns were diverse, and quite differ-
ent from those in the overall EPIC II study population,
in which staphylococci were isolated most frequently, and
Gram-positive and Gram-negative organisms were equally
present [1]. In the patients with abdominal infections, the
picture was substantially different: Gram-negative bacteria
were isolated almost twice as frequently as Gram-positive
bacteria, with E. coli being the most prevalent pathogen;
typical nosocomial microorganisms, such as P. aeruginosa
and Enterobacter spp. were also frequently isolated. Indeed,
P. aeruginosa was the second most frequently isolated
Gram-negative microorganism, which may in part be due
to the design of the study, but the percentages are com-
parable to other studies in this field [25]. Among the
Gram-positive microorganisms, enterococci were most
prevalent, whereas staphylococci were uncommon. Fur-
thermore, there were important differences in micro-
biology between survivors and non-survivors, with
P. aeruginosa and Stenotrophomonas maltophilia iso-
lated twice and four times more often, respectively, in
non-survivors than in survivors. These pathogens may
have a greater degree of pathogenicity (although Steno-
trophomonas is generally not considered to be a major
pathogen), or may be more difficult to treat. Detailed data
regarding antibiotic resistance, including information re-
garding resistance to specific antibiotics, were not collected
so we are unable to comment further on these aspects.
The findings in this study suggest that physicians
around the world seem to comply with international
guidelines in this field as most patients receive broad-
spectrum antibiotics, often in combination with agents
aimed at fungi or even at resistant Gram-positive micro-
organisms. We also found that patients who had stayed
in the ICU for 2 days or less on the study day had differ-
ent characteristics to those who had been longer on the
ICU. Microbiological isolates and antibiotic treatments
were remarkably different between these groups with
fewer carbapenems, glycopeptides and antifungals used
in patients with shorter stays. Current guidelines for the
selection of antibiotic therapy in critically ill patients do
not mention length of stay in the hospital as a consider-
ation for empirical treatment in patients with high-severity
non-nosocomial infections. Nevertheless, this group repre-
sents a category of patients, presumably with community-
acquired infection, who could potentially be treated with
narrower spectrum antibiotics when local ecology allows.
This hypothesis warrants further evaluation.
Fungal infections have received considerable attention
in the last decade. Although the debate continues as to
whether fungi are relevant in community-acquired dis-
ease, the situation is different in nosocomial infections
and in severely ill patients [20]. Candida isolation has
been identified as an independent predictor of mortality
in some studies [19,26,27], which has triggered wide-
spread use of empiric antifungal coverage with flucona-
zole in this setting. In the current study, fungi were
isolated in approximately 1 in 6 patients, but antifungal
therapy was administered to almost 30% of the patients,
reflecting the high use of antifungal prophylaxis in this
group. Fungi were found more often in patients who had
been in the ICU for more than 2 days, but were not
linked to mortality in the current study. Identifying
which patients are at risk of fungal infection and may





Hematological cancer 4.04 (1.47-11.11) <0.01
Mechanical ventilation 2.97 (2.03-4.35) <0.001
Cirrhosis 2.35 (1.29-4.30) <0.01
RRT (hemodialysis or hemofiltration) 1.51 (1.03-2.21) 0.04
SAPS II score on the study day (per point) 1.06 (1.05-1.07) <0.001
Legend. Adjusted for hospital, organizational factors and for geographic region.
CI = confidence interval; SAPS II = Simplified Acute Physiology Score II; RRT = renal
replacement therapy. Hosmer-Lemeshow goodness of fit: chi2 = 5.315 with 8 df,
p-value = 0.723; the c-statistic 0.82 (95%CI:0.80-0.85), p-value < 0.0001.
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benefit from preemptive antifungal therapy remains a
challenge; length of stay in the hospital and other risk
factors for fungal infection, such as upper gastro-
intestinal tract perforation and previous antibiotic
exposure [28], should be considered before initiating
antifungal therapy. The prevalence of Candida non-
albicans isolates was lower than frequently reported in
invasive candidiasis studies or other studies in patients
with Candida peritonitis. For example, Montravers
et al. reported that only 58% of patients with Candida
peritonitis had C. albicans isolated from intraoperative
cultures [18]. In patients with invasive candidiasis, a
systematic review by Andes et al. indicated that just
44% of the isolates were C. albicans [29]; patients with
Candida peritonitis accounted for only 1% of the pa-
tients in this review, however. It is not clear whether
the infecting Candida species or its susceptibility plays
a major role in determining outcome [18].
This study has a number of limitations. Because the
study was not primarily focused on abdominal infec-
tions, the exact source and extent of infection were
not recorded and the efficacy of source control and
appropriateness of antimicrobial therapy could not be
evaluated. The rate of superinfection and/or tertiary peri-
tonitis could not be assessed. Data on the community-
acquired versus nosocomial nature of infections were also
not available and we, therefore, used the length of stay as
a surrogate marker, but acknowledge that this has its limi-
tations. Finally, as in all point-prevalence studies, patients
who are admitted for a long period of time may skew the
findings with more data collected on those who stay in the
ICU for a longer period of time.
Table 5 Microbiology and antibiotic use in patients who
had been admitted for 2 days or less vs. more than








260 (53) 669 (74.4) <0.001
Gram-positive bacteria
Methicillin-sensitive S aureus 10 (3.8) 11 (1.6) 0.04
Methicillin-resistant
Staphylococcus aureus








5 (1.9) 20 (3.0) 0.37
Enterococci, ampicillin-sensitive 22 (8.5) 100 (14.9) <0.01
Group A, B, C, G Streptococcus 4 (1.5) 10 (1.5) 0.96
Streptococcus pneumoniae 1 (0.4) 4 (0.6) 0.69
Streptococcus, other than group
A, B, C and D
11 (4.2) 20 (3) 0.34
Gram-positive cocci, other 2 (0.8) 6 (0.9) 0.85
Gram-positive bacilli, other 2 (0.8) 6 (0.9) 0.85
Enterococci, ampicillin-resistant 23 (8.8) 47 (7.0) 0.35
Gram-negative bacteria
Escherichia coli 74 (28.5) 137 (20.5) <0.01
Enterobacter spp. 22 (8.5) 55 (8.2) 0.91
Klebsiella spp. 21 (8.1) 64 (9.6) 0.48
Proteus spp. 13 (5.0) 34 (5.1) 0.96
Salmonella spp. 2 (0.8) 5 (0.7) 0.97
Serratia spp. 2 (0.8) 3 (0.4) 0.55
Citrobacter spp. 1 (0.4) 12 (1.8) 0.10
Pseudomonas aeruginosa 17 (6.5) 69 (10.3) 0.08
Pseudomonas, other than P
aeruginosa
0 (0.0) 4 (0.6) 0.21
Stenotrophomonas maltophilia 5 (1.9) 12 (1.8) 0.90
Acinetobacter spp. 8 (3.1) 27 (4) 0.49
Campylobacter spp. 4 (1.5) 3 (0.4) 0.09
Haemophilus spp. 0 (0.0) 2 (0.3) 0.38
Enterobacteria, other 4 (1.5) 5 (0.7) 0.27
Bacillus 3 (1.2) 10 (1.5) 0.69
Anaerobes
Clostridium 21 (8.1) 72 (10.8) 0.22
Anaerobic cocci 2 (0.8) 5 (0.7) 0.97
Bacteroides 9 (3.5) 20 (3.0) 0.71
Anaerobes, other 9 (3.5) 6 (0.9) <0.01
Mycobacteria 1 (0.4) 1 (0.1) 0.49
Table 5 Microbiology and antibiotic use in patients who
had been admitted for 2 days or less vs. more than
2 days on the study day (Continued)
Fungi
Candida albicans 29 (11.2) 89 (13.3) 0.38
Candida non-albicans 6 (2.3) 32 (4.8) 0.09
Aspergillus 0 (0.0) 2 (0.3) 0.38
Fungi, other 1 (0.4) 4 (0.6) 0.69
Antibiotic use
Cephalosporins 115 (23.4) 145 (16.1) <0.001
Penicillins 191 (38.9) 290 (32.3) 0.01
Other beta lactams 116 (23.6) 331 (36.8) <0.001
Aminoglycosides 64 (13.0) 114 (12.7) 0.85
Quinolones 67 (13.6) 131 (14.6) 0.64
Glycopeptides 78 (15.9) 252 (28) <0.001
Macrolides 7 (1.4) 23 (2.6) 0.17
Other antibiotics 194 (39.5) 355 (39.5) 0.99
Antifungals 80 (16.3) 266 (29.6) <0.001
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Conclusion
In conclusion, this study found that abdominal infec-
tions were present in about one fifth of ICU patients on
the study day and concomitant infections were common.
Microbiology patterns and choice of antibiotic therapy
were diverse and differed in patients who had stayed in
the ICU for 2 days or less compared to those with longer
stays. Abdominal infections carry a poor prognosis, with
higher mortality rates than in patients with infections
from other sources. Disease severity, need for organ sup-
port and presence of comorbidities were independently
associated with mortality in our cohort.
Appendix: List of participating centers by country,
alphabetically
Andorra: Hospital Nostra Senyora de Meritxell (A
Margarit); Argentina: Centro de Educación Médica
E Investigaciones Clínicas (R Valentini); Clinica de
Especialidades Villa Maria (AJ Zazu); Clínica Modelo
de Morón (C Bevilacqua); Clinica Y Maternidad Suizo
(M Curone); CMIC (R Rabuffetti); Hospital Aleman (P
Comignani); Hospital Argerich (M Torres Boden);
Hospital Britanico (F Chertcoff ); Hospital Central de
San Isidro (G Cardonatti); Hospital de Niños Dr. Héctor
Quintana (F Adén); Hospital del Niño Jesús (L Marcos);
Hospital Dr Pedro Ecay (M Dónofrio); Hospital Español de
Mendoza (R Fernández); Hospital Español Medical Plaza (R
Lamberghini); Hospital Internacional General de Agudos
"José de San Matín" (S Balasini); Hospital Interzonal Dr. O.
Alende (J Teves); Hospital Italiano de Buenos Aires (M Las
Heras, J Sinner); Hospital Juan A. Fernández (D Ceraso);
Hospital Municipal de Chivilcoy (D Curcio); Hospital
Profesor Alejandro Posadas (L Aguilar); Hospital Provincial
de Rosario (C Weller); Hospital Provincial del Centenario
(L Cardonnet); Hospital Regional Rio Gallegos (R Santa
Cruz); Hospital Regional Ushuaia (E Manrique); Hospital
Universitario Austral (D Bernardez, T Iolster); Hospital
Universitario Universidad Abierta Interamericana (G
Chiappero); Instituto Privado del Quemado Med-Inter
(D Curcio); Nuevo Hospital El Milagro (P Ramos);
Ramos Mejia Hospital (J Vergara); Sanatorio Agote
(I Moine); Sanatorio de la Trinidad Mitre (S Ilutovich);
Sanatorio de Los Arcos (G Jannello); Sanatorio Dupuytren
(M Waschbusch); Sanatorio Frangioli de Salud 2000
Srl (G Rios Picaza); Sanatorio Mater Dei (A Raimondi);
Sanatorio Otamendi Y Miroli (M Miriam); Sanatorio
Parque (L Carlos); Sanatorio San José (D Curcio);
Armenia: Centro Gallego de Buenos Aires (M Caridi);
Australia: Alfred Hospital (T Leong); Barwon Health
(N Orford); Blacktown Hospital (G Reece); Box Hill
Hospital (D Ernest); Cabrini Hospital (F Hawker);
Concord Repatriation General Hospital (J Tan); Epworth
Eastern Private Hospital (C Giannellis); Epworth Hospital
Richmond (B Ihle); Flinders Medical Centre (A Bersten);
Frankston Hospital (J McInnes); Gold Coast Hospital (M
Tallott); John Hunter Hospital (B Mcfadyen); Joondalup
Health Campus (J Vibert); Liverpool Hospital, Sydney
South West Area Health Service (M Parr); Logan Hospital
(K Tran); Mater Health Services (J Sutton); Mount Hospital
(S Webb); Nambour General Hospital (N Groves); Nepean
Hospital, NSW (L Cole); Prince Charles Hospital (D Long);
Prince of Wales Hospital (F Bass); Princess Margaret
Hospital For Children (S Erickson); Royal Brisbane and
Womens' Hospital (J Lipman); Royal Children’s Hospital,
Brisbane (D Long); Royal Children’s Hospital, Melbourne
(C Delzoppo); Royal Darwin Hospital (J Thomas); Royal
Perth Hospital (G Dobb); Royal Prince Alfred Hospital (M
Daley); Sir Charles Gairdner Hospital (B Roberts); St John
of God Hospital, Subiaco (S Webb); St Vincent’s Hospital,
Melbourne (J Santamaria); Sydney Children’s Hospital (J
Young); The Children’s Hospital at Westmead, Sydney (M
Festa); The John Flynn Private Hospital (R Holland);
The Prince Charles Hospital (D Mullany); The Queen
Elizabeth Hospital (P Williams); The Townsville Hospital
(M Corkeron); The Wollongong Hospital (M Gales);
Westmead Hospital (A Banerjee); Women’s and Children’s
Hospital, Adelaide (M Yung); Austria: University Hospital
Innsbruck (N Mutz, M Hiesmayr); General Hospital (P
Faybik); Hospital Hietzing (R Fitzgerald); Krankenhaus
Barmherzige Brüder Linz (F Firlinger); Krankenhaus Der
Barmherigen Brueder Wien (G Zasmeta); Krankenhaus
Der Barmherzigen Brüder St. Veit (M Zink); Krankenhaus
Der Barmherzigen Schwestern Linz (W Sieber); Kranken-
haus Steyr (J Hildegard); Landeskrankenhaus Klagenfurt
(R Bakondy); Landeskrankenhaus Stolzalpe (J Schlieber);
Landeskrankenhaus Deutschlandsberg (G Filzwieser);
Medical University Innsbruck (R Beer, M Joannidis);
Medical University of Vienna (T Staudinger); Otto-Wagner
Hospital (R Schuster); Unfallkrankenhaus Meidling Der
Auva (W Scherzer); University Hospital (K Smolle);
Wilhelminenspital (S Fitzal); Bangladesh: Central Hospital
Limited (R Manzoor); Belgium: A.I.T. (J Brunain);
Ambroise Paré (A Dive); Asz-Aalst (G Huylenbroeck);
Az Groeninge Kortrijk (M Van der Schueren); Az
Maria Middelares (H 't kindt); Az Sint Jozef Malle (E
Slock); Az Sint Lucas (D Rijckaert); Az St Augustinus
(J Raemaekers); Az St Jan Av (M Bourgeois); Az Vesalius
(I Van Cotthem); Az Damiaan Oostende (G Nackaerts);
C.H.N.D.R.F. (D Gusu); Centre Hospitalier de Mouscron
(P Gadisseaux); CH Libramont (V Olivier); Chirec -
Braine-L'Alleud (H Lignian); CHPLT Verviers (P Michel);
CHR Citadelle (V Fraipont); CHR Haute Senne Soignies
(M Van der Stappen); CHR St Joseph Mons-Warquignies
(F Forêt); CHU Brugmann (D De Bels, J Devriendt, J
Massaut); CHU Charleroi (P Biston); CHU Saint-Pierre (A
Roman); CHU Sart Tilman, Liège (B Lambermont);
Clinique Sainte Elisabeth (A De Meulder); Clinique
Notre Dame (V Frederic); Clinique Notre-Dame de
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Grâce (T Sottiaux); Clinique Saint Luc, Bouge (P
Ruyffelaere); Cliniques de L'Europe, St-Michel (V Collin);
Cliniques de L'Europe, Ste Elisabeth (S Anane); Hôpital
Francais (P Kleiren); Hôpital Saint-Joseph (M Simon);
Hornu (S Machayekhi); Imeldaziekenhuis (E Frans); Institut
Jules Bordet (G Leroy, T Berghmans); Jan Yperman
Hospital (R Joseph); Olv Ter Linden Ziekenhuis,
Knokke (J Eerens); Saint Luc University Hospital (PF
Laterre); Sint Augustinus, Veurne (B Lagrou); St Vincent (R
Rutsaert); St-Jozefkliniek Bornem-Willebroek (W Pisarek);
UCL Mont-Godinne (A Dive); Universitair Ziekenhuis
Gent (J De Waele); University Hospital Brussels (H Spa-
pen); University Hospital of Liege (P Damas); Erasme
University Hospital (JL Vincent); ZNA Stuivenberg (M
Malbrain); Belize: Universal Health Services, Medical
Center (J Hidalgo); Brazil: Bandeirantes Hospital (M
Baptista); Barra Dor Hospital (D Salgado); Biocor Instituto
(M Braga); Casa de Saude Sao Jose Caxias (C Avila); Centro
Hospitalar Unimed (G Westphal); Centro Integrado de
Atençaõ À Saúde -Unimed Vitória (E Caser); Clínica São
Vicente da Gávea (A Alves); Complexo Hospitalar Santa
Casa de Porto Alegre (G Friedman); Erasto Gaertner
Hospital (M Luz); Federal University of Sao Paulo (M
Assuncao); Fundacao Hospital de Clinicas Gaspar Vianna
(H Reis); Fundação Hospitalar Do Estado de Minas Gerais -
Fhemig (A Gomes); Fundação Pio Xii (U Silva); UNIFESP
(W Nogueira Fh); Hopital das Clínicas - FMUSP (S El-
Dash); Hospital Padre Albino-Faculdade de Medicina de
Catanduva (J Valiatti); Hospital Alberto Cavalcanti
(A Barbosa); Hospital Badim (C Coelho); Hospital
Cardiotrauma Ipanema (M Knibel); Hospital Carlos
Fernando Malzoni (C Minelli); Hospital Da Cidade de
Passo Fundo (J Caovilla); Hospital das Clínicas da
Faculdade de Medicina de Ribeirão Preto da Universi-
dade de São Paulo (G Teixeira); Hospital das Clínicas,
Universisty of São Paulo (A Hovnanian); Hospital das
Nacoes (A Rea-Neto); Hospital de Base-Famerp (SL
Lobo); Hospital de Clínicas Mario Lioni (M Lugarinho);
Hospital de Clínicas Niterói (P Souza); Hospital de Doenças
Tropicais de Goiânia (D Ferreira); Hospital do Cancer/
Uopeccan (P Duarte); Hospital do Trabalhador (M
Oliveira); Hospital dos Servidores do Estado Rio de
Janeiro (J Marques); Hospital E Maternidade São José
(R Machado); Hospital Estadual Diadema (P Rehder);
Hospital Estadual do Grajau-Unisa (S Mataloun); Hospital
Evangelico (M Grilo); Hospital Evangelico do Rio de Janeiro
(P Quesado); Hospital Geral de Pedreira (M Moock);
Hospital Geral de São Mateus (F Ferreira); Hospital Geral
Roberto Santos (J Teles); Hospital Israelita Albert Einstein
(E Silva); Hospital Israelita Albert Sabin (C Coelho);
Hospital Júlia Kubitschek (A Morais); Hospital Mater
Dei (F Carvalho); Hospital Memorial Arthur Ramos (M
Wanderley); Hospital Meridional (M Velasco); Hospital
Moinhos de Vento (N Brandão da Silva); Hospital
Municipal São José (J Feijó); Hospital Nossa Senhora Da
Salete (P Duarte); Hospital Pasteur (V Souza Dantas);
Hospital Português (J Teles); Hospital Pró-Cardíaco (R
Costa Filho); Hospital Quinta D'Or (A Japiassu); Hospital
Regional Antônio Dias (D Villela); Hospital Regional de
Barbacena (C Santos); Hospital Salvador (R Passos);
Hospital Samaritano (R Alheira-Rocha); Hospital Santa
Izabel (R Silva); Hospital Santa Paula (J Houly); Hospital
Sao Cristovao (J Aldrighi); Hospital São Lucas (R Hatum);
Hospital São Lucas da PUCRS (F Suparregui Dias); Hospital
São Luiz - Unidade Itaim (L Ferreira); Hospital São Rafael
(L Ferro); Hospital São Vicente de Paulo (J Gomez);
Hospital Universitário Clementindo Fraga Filho - Ufrj
(R Fleury); Hospital Universitario da Universidade Federal
do Rio de Janeiro (C David); Hospital Universitário de
Santa Maria (T Resener); Hospital Universitário do
Oeste do Paraná (P Duarte); Hospital Universitário
Lauro Wanderley - UTI Adulto (C Mendes); Hospital
Universitario Regional de Maringa (A Germano); Hos-
pital Vita Curitiba (M Oliveira); Hospital Vivalle (F De
marco); Instituto de Espquisa Clinica Evandro Chagas
(A Japiassu); Instituto Do Coração - HC-FMUSP (S
Lage); Instituto Nacional de Cancer (J Salluh); Irman-
dade Santa Casa de Misericordia de Porto Alegre (A
Torelly); Luxemburgo Hospital (R Sad); Mternidade
Odete Valadares (A Barbosa); Prontocor Lagoa (G
Oliveira); Samaritano Hospital (R Lima); Santa Casa
Da Misericórdia de São João del Rei (J Paranhos); Santa
Casa de Misericordia de Passos (M Oliveira); Santa
Casa de Porto Alegre (M Rocha); São Sebastião Hospital
(W Bitencourt); Universidade Federal Do Parana (A
Rea-Neto); University of Londrina (C Grion); University of
Sao Paulo (D Forte); Uti Da Disciplina de Clínica
Médica-Unifesp (H Guimarães); Vitória Apart Hospital
(C Piras); Bulgaria: Mbal Ruse (L Stephanova); Multiprofile
Hospital of Active Treatment, Ruse (L Lyubenov); Uh
St. Ekaterina (G Tsarianski); Univerisity Hospital (G
Dimov); Canada: Capital Health-Queen Elizabeth II
Health Sciences Centre (R Green); Centre Hospitalier
Régional de Lanaudière (J Levasseur); Children’s Hospital
of Eastern Ontario (R Ward); CHU Sherbrooke (O Lesur);
Hôpital Charles Lemoyne (G Poirier); Mount Sinai Hospital
(R Wax); Royal Jubilee Hospital (G Wood); St. Joseph’s
Healthcare (D Cook); St. Michael’s Hospital (J Marshall);
Toronto General Hospital (M Herridge); Toronto Western
Hospital (N Ferguson); Victoria General Hospital (G
Wood); Chile: Clinica Alemana de Santiago (M Espinoza);
Clinica las Condes (S Valdés jimenez); Hospital Clínico de
la Pontificia Universidad Católica de Chile (A Bruhn);
Hospital del Trabajador (J Micolich); Hospital Dr G. Fricke
(S Galvez); Hospital El Pino (I Escamilla Leon); China:
Beijing Chaoyang Hospital (Q Zhan); Beijing Tongren
Hospital (Y Xu); Chinense Pla General Hospital (Y Zhao);
Fuxing Hospital, Capital Medical University (L Zhang);
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Guangdong Provincial People’s Hospital (T Qin); Peking
Union Medical College Hospital (B Du); Peking University
People’s Hospital (M Li); Ren Ji Hospital,Shanghai Jiao
Tong University (X Wang); The Affiliated Hospital of
Ningxia Medical College of China (Y Jing); The First
Affiliate Hospital of China Medical University (Z Zhang);
The First Affiliated Hospital of Dalian Medical University
(W Xianyao); The First People’s Hospital of Nantong,
Jiangsu (F Li); Zhong-Da Hospital and School of Clinical
Medicine, Southeast University (Y Congshan); Colombia:
Clinica General del Norte (C Rebolledo); Clinica Central
del Quindio (D Diaz); Clinica Medellin (R Murillo
Arboleda); Clinica Saludcoop (C Rebolledo); Clinica
Santa Isabel de Valledupar. (A Arias Antun); Fundación
Hospital San Carlos (G Montenegro); Fundacion Valle
del Lili (M Granados); Hospital Bocagrande de Cartagena
(C Duenas); Hospital Departamental de Villavicencio (N
Perez); Hospital El Tunal (G Libreros Duque); Hospital
San Jose de Bogota (M Coral); Hospital Santa Clara (G
Ortiz); Costa Rica: Hospital Calderón Guardia CCSS (D
Rodriguez); Croatia: Hospital for Infectious Diseases
(B Barsic); Sveti Duh General Hospital, School of
Medicine, Zagreb (M Cubrilo-Turek); University Hospital
Centre (I Gornik); University Hospital Zagreb (M Grljusic);
Cuba: Hospital Universitario Arnaldo Milian Castro (A
Caballero lopez); Hospital Universitario Dr. Gustavo
Aldereguía Lima (M Iraola ferrer); Czech Republic:
Centre of Cardivascular and Transplant Surgery (P
Pavlik); Charles University Teaching Hospital, Hradec
Kralove (J Manak); Charles University Medical School
and Teaching Hospital (J Radej); Faculty General Hospital,
Charles University Prague (J Belohlavek); Faculty Hospital
Brno (P Sevcik); Faculty Hospital Olomouc (L Blahut);
General Teaching Hospital of 1St Faculty and Charles
University (D Tyl); Horovice Hospital (J Steinbach);
Klaudians Hospital (I Herold); Krajska Nemocnice Liberec
(I Zykova); Nemocnice V Usti Nad Orlici (D Prchal); St.
Anne’s University Hospital Brno (T Bartosik); University
Hospital Brno (M Kolarova); University Hospital Olomouc
(R Hájek, J Kohoutová, O Marek); University Hospital
Ostrava (P Hon); University Hospital Plzen (I Chytra);
Denmark: Århus University Hospital (H Betsch); Næstved
Hospital (B Fogh); Rigshospitalet (K Espersen); Sygehus Fyn
(K Jacobsen); Vejle Sygehus (P Berezowicz); Ecuador:
Carlos Andrade Marín Hospital (F Guerrero); Clinica La
Merced (E Salgado); Hospital Eugenio Espejo (D Barahona);
Hospital General de Las Fuerzas Armadas del Ecuador Hg-
1 (H Del pozo sanchez); Hospital Metropolitano (M Jibaja);
Egypt: Dar Alfouad Hospital (A Alansary); Estonia: East
Tallinn Central Hospital (A Reintam); Tartu University
Hospital (J Starkopf); Finland: Helsinki University Central
Hospital (V Harjola); France: AP-HP, CHU Jean Verdier
(L Tual); Assistance Publique-Hôpitaux de Marseille,
CHU Nord (M Leone); Centre Hospitalier Dunkerque
(M Serge); Centre Hospitalier Universitaire (P Michel);
Centre Hospitalier (O Leroy); Centre Hospitalier D'Auch
(L Mallet); Centre Hospitalier de Blois (B Marc); Centre
Hospitalier de Fougères (D Dormoy); Centre Hospitalier de
Niort (H Pascal); Centre Hospitalier Dr Schaffner (L
Tronchon); Centre Hospitalier du Pays D'Aix (B Garrigues);
Centre Hospitalier Region Annecy (C Santré); Centre
Hospitalier Universitaire Amiens (H Dupont); Centre
Hospitalier Universitaire de Bicêtre (J Duranteau); Centre
Hospitalier Universitaire Reims (A Leon); CH Colmar (L
Henry); CHG Armentieres (C Canevet); CHU Angers (L
Dube); CHU Angers (H Julien); CHU Bicetre (A Nadia);
CHU Brest (B Francois); CHU de Bordeaux (J Gérard);
CHU Dijon Hopital Général (M Freysz); CHU Hôtel Dieu -
APHP (G Remy); CHU Nantes (Y Blanloeil); Clinique
Ambroise Paré (P Squara); General Hospital (J Korach);
Grenoble University Hospital (M Durand); Groupe Hospi-
talier du Havre (C Gabriel); Hia Laveran (P Eric); Hopital
Antoine Béclère APHP (F Jacobs); Hopital Bichat (R
Bronchard); Hôpital Claude Huriez, Centre Hospitalier
Régional Universitaire de Lille (E Kipnis); Hopital
Cochin Paris (M Moussa); Hôpital de Hautepierre (A
Launoy); Hopital de la Croix Rousse (C Guérin); Hôpital
Edouard Herriot (P Vanhems); Hôpital Maison Blanche (A
Wynckel); Hôpital Raymond Poincaré (B Clair); Hôpital
Saint-Louis (E Azoulay); Hôpital Tenon (J Fulgencio);
Hôpitaux Civils de Colmar (Y Gottwalles); Hôpitaux
Universitaires de Strasbourg (T Krummel); Hospices
Civils de Lyon (A Lepape); La Rochelle Hospital (O
Lesieur); Lariboisiere University Hospital (D Payen);
Poissy Hospital (O Hérvé); Polyclinique Saint André (J
Farkas); Rangueil Hospital (P Cougot); Réanimation
Chirurgicale (Y Malledant); University Hospital of
Bordeaux Haut-Lèvéque (O Joannes-Boyau); Germany:
Academic Hospital Solingen (T Standl); Ameos Klinikum
St.Salvator Halberstadt GMBH (U Sierig); Asklepios
Fachkliniken München-Gauting (J Geiseler); Asklepios
Klinik Langen (H Hopf); Behandlungszentrum Vogtareuth
(M Burgau); Bergmannsheil Bochum (E Conrad-Opel);
Bethanien-Krankenhaus (C Hermann); Bundeswehrkran-
kenhaus Ulm (M Ventzke); Charite/Campus Virchow-
Klinikum (T Henneberg); Charite Berlin-Buch (H
Loeser); Charité Campus, Mitte (C Spies); Charité
Campus, Virchow Klinikum (C Spies); Charite Campus,
Virchow (F Esposito); Charité Universitätsmedizin Berlin
(H Zuckermann-becker); Clemenshospitl (R Scherer);
Dominikus Krankenhaus (A Pauer); Drk-Kliniken Mark
Brandenburg (S Kljucar); Drk-Krankenhaus Ratzeburg
(K Delfs); Elisabeth-Krankenhaus Essen (E Blank); Ev.
Kliniken Bonn Betriebsstätte Waldkrankenhaus (J Busch);
Ev.-Freikirchliches Krankenhaus Rüdersdorf (K Wendt);
Evang. Krankenhaus Mülheim (J Leßmann); Evangelische
Kliniken Bonn Wadkrankenhaus (J Busch); Evangelisches
Krankenhaus Bielefeld (F Bach); Friedrich Schiller University,
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Jena (Y Sakr); Gemeinschaftskrankenhaus Herdecke (T
Berlet); Georg-August University of Göttingen (A
Kernchen); Georg-August-University of Göttingen (M
Quintel); Hanse-Klinikum Wismar (D Holst); Heart
clinic of the University of Munich (E Kilger); Helfenstein
Klinik (T Holubarsch); Helios Klinik Lengerich (C
Raufhake); Helios-Klinikum Berlin-Buch (R, Kuhlen, C
Stolt); Helios Klinikum Emil Von Behring (A Lubasch);
Helios Klinikum Erfurt Gmbh (A Meier-Hellmann);
Helios Klinikum Wuppertal Barmen (G Woebker);
Henriettenstift (C Scharnofske); Herz-Jesu-Krankenhaus
(M Breyer); Hochtaunus Kliniken Bad Homburg (T Risch);
Hospital Links Der Weser (C Manhold); Icu In Drk
Kliniken Mark Brandenburg (S Kljucar); J.W. Goethe -
University Medical School Frankfurt Am Main (D
Meininger); Johanniter Krankenhaus Bonn (C Greive);
Johanniter Krankenhaus Stendal Ggmbh (J Rau); Jung-
Stilling-Krankenhaus (A Seibel); Katharinenhospital
(A Henn-beilharz); Katholisches Krankenhaus Hagen
(R Wolbert); Krankenhaus Prignitz Gemmeinnützige
GMBH (T Scherke); Klinik Am Eichert (J Martin); Kli-
nik Für Herzchirurgie (M Rudolph); Klinik Füranästhesie,
Operative Intensivmedizin U. Schmerztherapie (J Gleißner);
Kliniken Ludwigsburg-Bietigheim GMBH (M Wolf );
Kliniken Maria Hilf (F Schleibach); Klinikum Augsburg
(U Jaschinski); Klinikum Bad Salzungen (A Lunkeit);
Klinikum Darmstadt (M Welte); Klinikum Der J.W.
Goethe-Universität (T Bingold); Klinikum Der Stadt
Wolfsburg (K. Sydow); Klinikum Emden (K Kogel-
mann); Klinikum Forchheim (F Fischer); Klinikum Fuerth
(B Fischer, M Schmid); Klinikum Grosshadern, Universität
München (M Klein); Klinikum Harlaching Städtisches
Klinikum Muenchen (A Bechtold); Klinikum Hildesheim
(K Bodmann); Klinikum Kaufbeuren (J Klasen); Klinikum
Landsberg (H Meyrl); Klinikum Lippe - Detmold (J Goetz);
Klinikum Ludwigsburg (G Geldner); Klinikum Luedensc-
heid (T Helmes); Klinikum Meiningen GMBH (N Jensen);
Klinikum Minden (H Eickmeyer, W Lengfelder); Klinikum
Nürnberg (B Langenstein); Klinikum Rechts Der Isar
(R Bogdanski); Klinikum Rechts Der Isar Der Technischen
Universität München (S Jelen-Esselborn, A Umgelter);
Klinikum Region Hannover (F Dörr); Klinikum Region
Hannover Krankenhaus Großburgwedel (K Lüttje);
Klinikum Region Hannover, Krankenhaus Oststadt-
Heidehaus (D Heinemeyer); Klinikum Starnberg (M
Uhl); Klinikum Stuttgart - Olgahospital (P Schirle);
Klinikum Suedstadt (H Benad); Klinikum Traunstein
(M Glaser); Klinikum Uelzen (W Panzer); Klinikum
Worms (E Huettemann); Klinikverbund St. Ansgar,
Krankenhaus Bassum (R Stierwaldt); Klinikverbund
Süd-West (M Schappacher); Knappschaftskrankenhaus
Bochum-Langendreer (E Müller); Krankenhaus Freyung
(Rural Hospital) (W Stadlmeyer); Krankenhaus Lübbecke
(M Fantini); Krankenhaus Mol GMBH Strausberg (B
Dummer); Krankenhaus Nordwest (M Thörner); Kran-
kenhaus Nordwest (V Jost); Krankenhaus Reinbek (T
Loerbroks); Kreisklinik Trostberg (T Glück); Kreiskranken-
haus Bergstrasse (R Zimmermann); Kreiskrankenhaus
Calw (R Clement); Kreiskrankenhaus Mechernich GMBH
(R Hering); Kreiskrankenhaus Nagold (T Klinger);
Kreiskrankenhaus Rottweil (J Mehl); Kreiskrankenhaus
St. Marienberg Helmstedt (H Polozek); Leopoldina-
Krankenhaus (A Rothhammer); Ludmillenstift (R Seidler);
Lukas-Krankenhaus Bünde (P Lorenz); Lungenfachklinik
Amsee Waren Mueritz (M Lutze); Marienhospital Bruehl
(M Euler); Marienkrankenhaus Schwerte (M Heintz);
Martin Luther Universität Halle (M Winkler); Medizinische
Klinik (M Angstwurm); Mlu Halle-Wittenberg (K Krohe);
Mueritz-Klinikum Waren (T Treu); Neurological Intensive
Care Unit (T Steiner); Oberschwabenklinik Wangen (S
Locher); Orthopädische Klinik Markgröningen (A Walz);
Ostalb-Klinikum Aalen (P Zahn); Otto-Von-Guericke
Universität Magdeburg (W Brandt); Scivias-Krankenhaus
St. Josef (M Marks); Ska-Bileelfeld-Mitte (F Henning); St.
Antonius Hospital (U Janssens); St. Hildegardis Kranken-
haus Mainz (M Luethgens); St. Johannes Krankenhaus
(W Theelen); St. Johannes-Hospital (M Sydow); St.
Johannes-Hospital (M Weber); St. Josef-Hospital, Ruhr-
Universität Bochum (A Meiser); St. Josefs-Hospital (C
Deutschmann); St. Joseph Krankenhaus (C Buttner); St.-
Marien Hospital Lünen (M Jokiel); St. Marienhospital
Hamm (C Bozzetti); St. Vincentius Kliniken (B Jürgen);
St.-Elisabeth Krankenhaus Köln-Hohenlind (F Fiedler); St.-
Vincentius-Krankenhaus Speyer (K Wresch); Städtischen
Kliniken Neuss - Lukaskrankenhaus (A Kremer); Städ-
tisches Klinikum Karlsruhe (H Bleier); Städtisches Klinikum
Wiesbaden, Dr.-Horst-Schmidt-Kliniken Hsk (M Rueckert);
Staedtisches Klinikum Guetersloh (H Ditter); Staedtisches
Klinikum Muenchen Gmbh - Klinikum Harlaching (C
Peckelsen); Staedtisches Klinikum Muenchen Gmbh/Klini-
kum Bogenhausen (P Friederich); Staedtisches Klinikum
München - Klinikum Neuperlach (K Weber); Tübingen
University Hospital (W Krueger); Ubbo-Emmius-Klinik
Aurich (R Lowack); Überlingen Hospital (A Michalsen);
Uniklinikum Dresden (M Ragaller); Universitaetsklinikum
des Saarlandes (A Groeschel); Universitaetsklinikum
Mannheim (T Friedrich, U Hoffmann); Universität
Rostock (M Hinz); Universitätsklinikum Der Martin-
Luther-Universität Halle-Wittenberg (A Christel); Universi-
tätsklinikum Dresden Carl Gustav Carus (M Ragaller);
Universitätsklinikum Leipzig Aör (T Hartwig); Universitäts-
medizin Berlin Charité Campus Benjamin Franklin (S
Vögeler); University (M Weiss); University Childrens Hos-
pital Hauner (K Reiter); University Hospital (T Schwab);
University Hospital Cologne (U Trieschmann); University
Hospital Dusseldorf (D Kindgen-milles); University
Hospital Giessen and Marburg Gmbh - Giessen (J
Engel); University Hospital Lübeck (B Sedemund-
De Waele et al. BMC Infectious Diseases 2014, 14:420 Page 10 of 17
http://www.biomedcentral.com/1471-2334/14/420
adib); University Hospital Mainz (M Lauterbach); Uni-
versity Hospital Marburg (M Max); University Hospital
Muenster (T Volkert); University Hospital of Essen (C
Waydhas); University Hospital of Mannheim (S Hien);
University Hospital of Munich, LMU (J Briegel); Uni-
versity Hospital of Regensburg (V Guralnik); Univer-
sity Hospital Rwth Aachen (N Zoremba); University
Hospital Tübingen (R Riessen); University Hospital
Würzburg (W Müllges); University Medical Center
Hamburg-Eppendorf (A Nierhaus); University of Erlangen
(R Strauss); University of Freiburg (S Utzolino); University
of Giessen (J Thul); University of Greifswald (P Abel, M
Gründling, W Keßler); University of Heidelberg (K
Scheuren); University of Leipzig (E Lothar, U Kaisers, D
Schmitt, D Schneider); University of Rostock (D Vagts);
University of Saarland (H Rensing); University Hospital
Essen (B Schoch); Universty Hospital (K Kopp); Vivantes -
Klinikum Neukoelln (H Gerlach); Vivantes Klinikum
Prenzlauer Berg (M Corea); Vivantes-Klinikum Am
Urban (A Uhrig); Westkuestenklinikum Heide (S Schroe-
der); Westküstenklinikum Heide (F Jordan); Westpfalz-
Klinikum Kaiserslautern (T Huber); Zentralöklinikum
Augsburg (M Bittinger) Greece: Ahepa University Hos-
pital (E Sofianos); Athens University Medical School (A
Armaganidis); Evangelismos Hospital (C Routsi); G.Papa-
nikolaou (M Bitzani); General Hospital of Rethymno (A
Chalkiadaki); Henry Dunant Hospital (A Michalopoulos);
Hippokrateion Hospital Thessaloniki (E Mouloudi); Kat
General Hospital (E Ioannidou); Kat Hospital (P Myr-
ianthefs); Kat Hospital, Athens (D Koulenti); Konstanto-
poulio General Hospital (I Karampela); Lamia General
Hospital (G Kyriazopoulos); Red Cross Hospital of Athens
(K Mandragos); Thriassio Hospital of Eleusis (P Clouva-
molyvdas); University Hospital of Ioannina (A Moraiti);
University Hospital of Alexandroupolis (I Pneumatikos);
University Hospital of Rion, Patras (K Filos); University
Hospital of Thessaly (Larissa) (E Zakynthinos); University
of Athens, Medical Shcool (A Kotanidou); Xanthi General
Hospital (AVakalos) Hong Kong: Northern District Hospital
(A Cheng); Princess Margaret Hospital and Yan Chai
Hospital (T Buckley); The Chinese University of Hong
Kong (C Gomersall) Hungary: National Institute of
Neurosurgery (K Kiss); Péterfy Hospital Budapest (P
Tamási); Saint George Hospital Hungary (A Sarkany);
Semmelweis University (A Csomos); University of
Szeged (É Zöllei) India: Advanced Medicare Research
Institute (S Todi); B.D.Petit Parsee General Hospital (F
Udwadia); Bhailal Amin General Hospital (R Shah);
Bombay Hospital (P Amin); Breach Candy Hospital
Trust (F Udwadia); Care Hospitals (S Samavedam);
Christian Medical College (A Mathai); Cumballa Hill
Hospital & Heart Institute (M Patil); Deenanath Man-
geshkar Hospital (S Jog); Dr. S. N. Medical College (M
Gurjar); Escorts Heart Institute & Research Centre (M
Vats); Fortis Healthcare (A Varma); Global Hospitals (P
Gopal); Hinduja Hospital & Medical Research Center (F
Kapadia); Indraprastha Apoolo Hospitals (R Chawla);
Jehangir Hospital (S Iyer); Kalinga Hospital (S Sahu);
Kasturba Hospital (C Bakshi); Lokmanya Care Hospital
(D Ambike); Max Super Speciality Hospital (D Govil);
Medical Trust Hospital, Cochin (V Karipparambath);
Nh Hospital (J Chacko); Ruby Hall Clinic (P Sathe);
Rungta Hospital (N Rungta); Saifee Hospital (C Jani); Seth
Ramdas Shah Memorial Hospital & Research Centre (A
Bhome); Shree Medical Foundation (S Prayag); Sir Ganga
Ram Hospital (S Ray); Sundaram Medical Foundation
(R Rajagopalan); Tata Memorial Hospital (J Divatia);
Wockhardt Hospital (R Da costa); Wockhrdt Hospital
(T Shyam Sunder) Indonesia: Bintaro International
Hospital (P Wibowo); Hasan Sadikin Hospital (T
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